Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018)
Pharma-Bio Serv posted quarterly Cash from Discontinued Operations of 2325159.0 for Q4 2018, up 315.79% on a QoQ basis from 559219.0 in Q3 2018.
Pharma-Bio Serv (PBSV) has 1 years of Cash from Discontinued Operations data on file, last reported at 2325159.0 in Q4 2018.
- For the quarter ending Q4 2018, Cash from Discontinued Operations changed N/A year-over-year to 2325159.0; the trailing twelve-month figure through Jul 2019 stood at 2325159.0 (changed N/A YoY), and the FY2018 full-year result was 2728726.0, up 447.3% from the prior year.
- Cash from Discontinued Operations for Q4 2018 stood at 2325159.0, up from 559219.0 in the prior quarter.
- Across five years, Cash from Discontinued Operations topped out at 2325159.0 in Q4 2018 and bottomed at 277995.0 in Q2 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | - |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2018 | 2.33 Mn |
| Oct 31, 2018 | 2.33 Mn |
| Jul 31, 2018 | 559,219.00 |
| Jul 31, 2018 | 559,219.00 |
| Apr 30, 2018 | -277,995.00 |
| Apr 30, 2018 | -277,995.00 |
| Jan 31, 2018 | 122,343.00 |
| Jan 31, 2018 | 122,343.00 |